Simunovic Matthew P, Xue Kanmin, Jolly Jasleen K, MacLaren Robert E
Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom2Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom3Retinal Unit, Sydney Eye Hospital, Sydney, New South Wales, Australia4Save Sight Institute, Discipline of Ophthalmology, University of Sydney, Sydney, New South Wales, Australia.
Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom2Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
JAMA Ophthalmol. 2017 Mar 1;135(3):234-241. doi: 10.1001/jamaophthalmol.2016.5630.
The early decline and recovery of retinal structure and function following iatrogenic macular detachment for retinal gene therapy is not well characterized in those with relatively preserved central visual function. Here, the recovery of retinal structure and function over the first month following iatrogenic retinal detachment for the delivery of adeno-associated viral vector encoding Rab Escort Protein 1 is described as a part of gene therapy for choroideremia.
To study changes in both retinal structure and function during the first month following iatrogenic macular detachment surgery.
DESIGN, SETTING, AND PARTICIPANTS: This prospective interocularly controlled study was conducted between February 1 and December 31, 2015. Treatment consisted of a subretinal injection of 0.1 mL of a gene therapy solution containing 1 × 1011 viral particles performed unilaterally. The participants were 5 males, aged 23 to 71 years, with a clinical and genetic diagnosis of choroideremia.
Retinal structure and function were assessed at baseline, 1 week, and 1 month using optical coherence tomography, logMAR visual acuity, microperimetry, the Farnsworth-Munsell (FM) 100-hue test, and the Rayleigh match.
Five white male patients aged 23 to 71 years underwent unilateral subretinal gene therapy for genetically confirmed choroidermeia. Optical coherence tomographic images demonstrated a complete resolution of the resulting iatrogenic retinal detachment by 1 week in all 5 patients. At 1 month, the mean (SE) change in central foveal thickness was +9.6 (7.2) μm in treated eyes and +8.8 (12.6) μm in control eyes. The mean (SE) change in visual acuity was +5.4 (3.3) letters in treated eyes and +0.8 (3.1) letters in control eyes. At 1 month, the mean (SE) threshold sensitivity changes were -1.2 (2.1) dB in treated eyes and -1.0 (1.2) dB in control eyes. Color discrimination at the FM 100-hue changed little at 1 month (mean [SE] change in C-index, -0.2 [0.4] in treated eyes and 0.1 [0.2] in control eyes). Rayleigh matches in 1 patient were consistent with a diagnosis of pseudoprotanomaly, suggesting decreased effective optical density of the cone photopigments.
Retinal structural recovery-as assessed by optical coherence tomography-occurs soon after iatrogenic detachment. Similarly, visual acuity recovers or improves within 1 month of the procedure and may not be accompanied by improvements in threshold sensitivity or color discrimination. Changes in color matching in 1 patient suggest decreased optical density of the cone photopigments in the early postoperative period.
在中心视觉功能相对保留的患者中,医源性黄斑脱离后视网膜结构和功能的早期下降及恢复情况尚未得到充分描述。在此,描述了在为治疗无脉络膜症进行基因治疗时,在医源性视网膜脱离后的第一个月内视网膜结构和功能的恢复情况,该治疗通过递送编码Rab护送蛋白1的腺相关病毒载体进行。
研究医源性黄斑脱离手术后第一个月内视网膜结构和功能的变化。
设计、地点和参与者:这项前瞻性眼间对照研究于2015年2月1日至12月31日进行。治疗包括单侧视网膜下注射0.1 mL含有1×10¹¹个病毒颗粒的基因治疗溶液。参与者为5名男性,年龄在23至71岁之间,临床和基因诊断为无脉络膜症。
在基线、1周和1个月时,使用光学相干断层扫描、logMAR视力、微视野计、Farnsworth-Munsell(FM)100色调试验和瑞利匹配评估视网膜结构和功能。
5名年龄在23至71岁之间的白人男性患者接受了单侧视网膜下基因治疗,基因检测确诊为无脉络膜症。光学相干断层扫描图像显示,所有5名患者在1周时医源性视网膜脱离均完全消退。在1个月时,治疗眼中心凹厚度的平均(标准误)变化为+9.6(7.2)μm,对照眼为+8.8(12.6)μm。治疗眼视力的平均(标准误)变化为+5.4(3.3)个字母,对照眼为+0.8(3.1)个字母。在1个月时,治疗眼的平均(标准误)阈值敏感度变化为-1.2(2.1)dB,对照眼为-1.0(1.2)dB。在FM 100色调试验中,1个月时颜色辨别变化不大(治疗眼C指数的平均[标准误]变化为-0.2[0.4],对照眼为0.1[0.2])。1名患者的瑞利匹配结果与伪红绿色盲的诊断一致,提示视锥色素的有效光密度降低。
通过光学相干断层扫描评估,视网膜结构在医源性脱离后很快恢复。同样,视力在手术后1个月内恢复或改善,且可能未伴有阈值敏感度或颜色辨别能力的改善。1名患者的颜色匹配变化提示术后早期视锥色素的光密度降低。